Gem Pharmaceuticals
941 Lake Forest Circle
Birmingham
Alabama
35244
United States
Tel: 205-982-8383
Website: http://www.gempharmaceuticals.com
About Gem Pharmaceuticals
Gem Pharmaceuticals is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically designed to eliminate the critical cardiotoxicity side effect of this powerful class of chemotherapeutics while maintaining their well-documented anti-cancer efficacy.4 articles about Gem Pharmaceuticals
-
ASCO2016: Gem Pharmaceuticals Presents Promising Phase 2 Data For GPX-150 In Sarcoma Patients At The 2016 ASCO Annual Meeting
6/7/2016
-
Gem Pharmaceuticals Receives U.S. Orphan Drug Designation For GPX-150 In The Treatment Of Patients With Sarcoma
1/6/2016
-
Gem Pharmaceuticals Announces Enrollment Of Initial Patients In Its Phase 2 Clinical Trial To Assess The Efficacy And Safety Of GPX-150 In Sarcoma Patients
1/23/2015
-
Gem Pharmaceuticals Acquires Vistek Medical
5/28/2010